The longitudinal tau PET imaging after 2 years reinforces the distinction between the AD and SNAP groups by showing an increase of tau binding in AD patients, especially in the parietal and temporal cortices, which contrasts with the stability of tau binding in SNAP patients, including those with positive PiB-PET. This evidence concerns the gene MAPT and Alzheimer disease.